4D Molecular Therapeutics
FDMT
FDMT
140 hedge funds and large institutions have $630M invested in 4D Molecular Therapeutics in 2024 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 57 increasing their positions, 44 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
12% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 25
48% less capital invested
Capital invested by funds: $1.2B → $630M (-$574M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
140
Holding in Top 10
–
Calls
$1.66M
Puts
$1.21M
Top Buyers
| 1 | +$37.4M | |
| 2 | +$11.8M | |
| 3 | +$9.25M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$7.33M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$5.67M |
Top Sellers
| 1 | -$61.6M | |
| 2 | -$10.9M | |
| 3 | -$9.8M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$7.26M |
| 5 |
Goldman Sachs
New York
|
-$5.87M |